Caribou Biosciences Inc (CRBU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 2,024 | 3,464 | 2,429 | 3,558 | 23,662 |
| Gross Profit | 2,024 | 3,464 | 2,429 | 3,558 | 23,662 |
| Operating Expenses | 40,262 | 46,965 | 48,431 | 41,000 | 38,295 |
| Operating Income | -38,238 | -43,501 | -46,002 | -37,442 | -14,633 |
| Other Income | 3,554 | 5,804 | 4,768 | 3,130 | 4,631 |
| Pre-tax Income | -34,684 | -37,697 | -41,234 | -34,312 | -10,002 |
| Net Income Continuous | -34,684 | -37,697 | -41,234 | -34,505 | -10,002 |
| Net Income | $-34,684 | $-37,697 | $-41,234 | $-34,505 | $-10,002 |
| EPS Basic Total Ops | -0.38 | -0.42 | -0.46 | -0.32 | -0.12 |
| EPS Basic Continuous Ops | -0.38 | -0.42 | -0.46 | -0.32 | -0.12 |
| EPS Diluted Total Ops | -0.38 | -0.42 | -0.46 | -0.32 | -0.12 |
| EPS Diluted Continuous Ops | -0.38 | -0.42 | -0.46 | -0.32 | -0.12 |
| EPS Diluted Before Non-Recurring Items | -0.38 | -0.42 | -0.46 | N/A | N/A |
| EBITDA(a) | $-38,284 | $-43,591 | $-46,831 | $-35,085 | $-15,498 |